Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies (NQ: DVAX )

11.49 -0.20 (-1.71%)
Official Closing Price Updated: 4:15 PM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dynavax Technologies

< Previous 1 2 3 4 5 6 Next >
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
DVAX earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Dynavax Technologies: Q4 Earnings Insights
Via Benzinga
Why Vera Therapeutics Stock Soared by 22% This Week
Executive changes and a bullish analyst take combined to boost sentiment on the company. 
Via The Motley Fool
3 Stocks Set to Soar 68% to 200% Higher
Analyst stock picks for outsized growth potential mean these companies should handily outperform the market averages. 
Via InvestorPlace
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript
DVAX earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Preview For Dynavax Technologies
Via Benzinga
Preview: Dynavax Technologies's Earnings
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
The Latest Analyst Ratings for Dynavax Technologies
Via Benzinga
Dynavax Technologies's Return On Capital Employed Insights
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Restaurant Brands International Inc. (NYSE: QSR) is a buy. 
Via Benzinga
JMP Securities Maintains Market Outperform Rating for Dynavax Technologies: Here's What You Need To Know
Via Benzinga
Dynavax Technologies Stock Sees Renewed Technical Strength
Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84. 
Via Investor's Business Daily
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
DVAX earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
The 7 Best Stocks Under $15 to Buy in June 2023
While you generally get what you pay for, these best stocks under $15 for June provide compelling opportunities at discount. 
Via InvestorPlace
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript
DVAX earnings call for the period ending March 31, 2023. 
Via The Motley Fool
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
The Top 7 Growth Stocks in Biotech
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
Via InvestorPlace
Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript
DVAX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Jim Cramer On This Stock Up 2% Over 6 Months: 'You've Got A Real Winner There'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Weyerhaeuser Co (NYSE: WY) a lot. 
Via Benzinga
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
From Clover Biopharmaceuticals
Via GlobeNewswire
The 7 Most Undervalued Long-Term Stocks to Buy in January
Investors should keep an eye on these severely undervalued long-term stocks as we get deeper into New Year 2023. 
Via InvestorPlace
Our 7 Top Small-Cap Stock Picks for 2023
Most of the names on this list of small-cap stock picks for 2023 are ready to rebound from a tough year in the markets. 
Via InvestorPlace
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
Via Benzinga
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
From Clover Biopharmaceuticals
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.